{ "ok": true, "cik": "1586554", "ticker": "CBDY", "name": "TARGET GROUP INC.", "filings": [ { "form": "10-Q", "filed": "2026-08-13", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1586554/000110465926095751/0001104659-26-095751-index.htm" }, { "form": "10-Q", "filed": "2026-05-15", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1586554/000110465926062758/0001104659-26-062758-index.htm" }, { "form": "10-K", "filed": "2026-03-31", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1586554/000110465926037856/0001104659-26-037856-index.htm" }, { "form": "10-Q", "filed": "2025-11-07", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1586554/000110465925108491/0001104659-25-108491-index.htm" }, { "form": "8-K", "filed": "2025-08-18", "items": [ "2.03 Creation of a Direct Financial Obligation" ], "url": "https://www.sec.gov/Archives/edgar/data/1586554/000110465925079347/0001104659-25-079347-index.htm" }, { "form": "10-Q", "filed": "2025-08-12", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1586554/000141057825001696/0001410578-25-001696-index.htm" } ], "events12m": 0, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001586554.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1586554" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up TARGET GROUP INC. ($CBDY). Last filing: 10-Q, 2026-08-13.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 3881003, "revenueGrowth1y": -0.4112221189767319, "revenueGrowthPerYear": null, "yearsOfData": 5, "operatingMargin": null, "operatingMarginPrior": null, "netMargin": -0.35034293969883556, "operatingCashFlow": -842425, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 108800, "longTermDebt": 7604276, "longTermDebtChange": 0.04978410766826746, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 0 }, { "fiscalYearEnd": "2022-12-31", "revenue": 0 }, { "fiscalYearEnd": "2023-12-31", "revenue": 3720169 }, { "fiscalYearEnd": "2024-12-31", "revenue": 6591625 }, { "fiscalYearEnd": "2025-12-31", "revenue": 3881003 } ], "totalEquity": -8062948, "totalAssets": 6176749, "equityRatio": -1.3053708350460735, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": -0.0022, "sharesOutstanding": 617025999, "bookValuePerShare": -0.013067436401492702, "revenuePerShare": 0.006289853274075733, "range80": { "low": 1676997.2575050923, "high": 3011237.2066224427, "baseline": 2285048.7225849465, "n": 749, "band": "b00" }, "ifPaceHeld": { "low": 1676997.2575050923, "high": 3011237.2066224427 } }, "edgarette": "🔖 Exposure: revenue $3.9M (FY2025), total debt $7.6M. Experience: revenue down 41.1% on the year. Soundness: equity -130.5% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.7M and $3.0M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, medicinal chemicals & botanical products): growth -41.1% against 1.7%.", "peers": { "sic": 2833, "sicDescription": "Medicinal Chemicals & Botanical Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2833", "growth": [ 0.0172, 10 ], "opMargin": [ 0.0073, 10 ], "equityRatio": [ 0.3327, 8 ] }, "summary": "Target Group Inc. (CBDY) saw revenue fall 41.1% in FY2025 to $4 million, equity -131% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
TARGET GROUP INC. against its own record and its peers
Revenue, on the yearPeer median 1.7%-41.1%Equity of assetsPeer median 33.3%-130.5%Gold tick: the median of 8–8 peers with $50M+ revenue in medicinal chemicals & botanical products
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-26T19:24:11.109Z", "hash": "5c92dffc54efe1f3", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Target Group Inc. (CBDY) saw revenue fall 41.1% in FY2025 to $4 million, equity -131% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 3881003, "totalDebt": 7604276, "cash": 108800 }, "experience": { "revenueGrowth1y": -0.4112221189767319, "revenueGrowthPerYear": null, "operatingMargin": null, "operatingMarginPrior": null, "netMargin": -0.35034293969883556, "freeCashFlow": null }, "soundness": { "equityRatio": -1.3053708350460735, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2833, "sicDescription": "Medicinal Chemicals & Botanical Products", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2833", "growth": [ 0.0172, 10 ], "opMargin": [ 0.0073, 10 ], "equityRatio": [ 0.3327, 8 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 1676997.2575050923, "high": 3011237.2066224427, "baseline": 2285048.7225849465, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 749, "sizeBand": "b00" }, "credibility": null, "stress": null, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-26T19:24:11.109Z", "hash": "5c92dffc54efe1f3", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001586554.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1586554" }, "speedCash": { "fiscalYear": 2025, "cashConversion": -0.2171, "growth3y": -0.4112, "volatility": 0.779, "paysDividend": false, "raisedDividend": false, "equityRatio": -1.3054, "quadrant": { "code": "sj", "label": "Slow and jumpy", "plain": "growing slower than its size class, with revenue that swings more" }, "compass": { "code": "fading", "inside": "Turns -21.7% of revenue into operating cash; revenue shrinking 41.1% a year over three years; no common dividend; liabilities exceed assets.", "outside": "Among under $50M companies: 55th percentile for cash, 8th for growth.", "emoji": "🍂", "label": "Fading", "plain": "slow and jumpy, lagging its peers" }, "band": "under $50M", "cashPctInClass": 55, "growthPctInClass": 8, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "balance", "text": "liabilities exceed assets (often from years of share buybacks, not always distress)" }, { "key": "slowjumpy", "text": "slow and jumpy: growing slower than its size class, with revenue that swings more" }, { "key": "cash", "text": "operating cash flow was negative" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±28%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 4, "name": "Rotting at the dock", "plain": "four or more warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -842425, "investing": 81379, "financing": -1064814, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 100118, "free": null }, { "fiscalYearEnd": "2022-12-31", "operating": -1014828, "free": null }, { "fiscalYearEnd": "2023-12-31", "operating": -589612, "free": null }, { "fiscalYearEnd": "2024-12-31", "operating": 2162684, "free": null }, { "fiscalYearEnd": "2025-12-31", "operating": -842425, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 108800, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 6176749, "ladder": null, "currentRatio": 0.17, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": -0.2171, "growth3y": -0.4112, "volatility": 0.779, "paysDividend": false, "raisedDividend": false, "equityRatio": -1.3054, "quadrant": { "code": "sj", "label": "Slow and jumpy", "plain": "growing slower than its size class, with revenue that swings more" }, "compass": { "code": "fading", "inside": "Turns -21.7% of revenue into operating cash; revenue shrinking 41.1% a year over three years; no common dividend; liabilities exceed assets.", "outside": "Among under $50M companies: 55th percentile for cash, 8th for growth.", "emoji": "🍂", "label": "Fading", "plain": "slow and jumpy, lagging its peers" }, "band": "under $50M", "cashPctInClass": 55, "growthPctInClass": 8, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "balance", "text": "liabilities exceed assets (often from years of share buybacks, not always distress)" }, { "key": "slowjumpy", "text": "slow and jumpy: growing slower than its size class, with revenue that swings more" }, { "key": "cash", "text": "operating cash flow was negative" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±28%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 4, "name": "Rotting at the dock", "plain": "four or more warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -842425, "investing": 81379, "financing": -1064814, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 100118, "free": null }, { "fiscalYearEnd": "2022-12-31", "operating": -1014828, "free": null }, { "fiscalYearEnd": "2023-12-31", "operating": -589612, "free": null }, { "fiscalYearEnd": "2024-12-31", "operating": 2162684, "free": null }, { "fiscalYearEnd": "2025-12-31", "operating": -842425, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 108800, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 6176749, "ladder": null, "currentRatio": 0.17, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }